Canada Approves Clinical Trials Of Anti-COVID-19 Vaccines

Canada strives to accelerate its research on vaccines and COVID-19 treatments 

On May 16, Canadian Prime Minister Justin Trudeau announced that the University's Dalhousie Vaccine Center was officially authorized by the Ministry of Health to begin clinical trials of COVID-19 vaccines.

According to the Vietnam News Agency, the National Research Council will work with vaccine manufacturers to produce locally if the trials are successful. Canada can embark on production and distribution of vaccine in the country.

Justin Trudeau emphasized that although the research and development of vaccines takes time and must be carried out in the right manner, it is clearly an encouraging message. The National Research Council will work with the vaccine manufacturers to produce locally if the trials are successful.

Canada currently records more than 75,000 COVID-19 cases, including more than 5,600 deaths. Health Canada says it has so far licensed 33 clinical trials in support of care and treatment of COVID-19.

Earlier, the National Research Council of Canada announced a partnership with China's bio-drug company CanSino Biologics Inc.; CanSinoBIO, to accelerate biological treatment and clinical trials of potential vaccines. COVID-19 against this country.